Abamectin Fruit Veg IR4 Morse
Abamectin Fruit Veg IR4 Morse
Abamectin Fruit Veg IR4 Morse
Meth-192, Page 2
TABLE OF CONTENTS
Page
1 PRINCIPLE..............................................................................................................3
2 EQUIVALENCE STATEMENT............................................................................3
5 REFERENCE STANDARDS..................................................................................7
8 SAMPLE EXTRACTION.......................................................................................14
11 CALCULATIONS ...................................................................................................18
12 REFERENCE...........................................................................................................20
1 PRINCIPLE
The method described herein is capable of determining abamectin residues (avermectin B1a,
avermectin B1b, and 8,9-Z avermectin B1a) in a variety of raw agricultural commodity (RAC)
fruits and vegetables. It is based on Novartis Crop Protection, Inc. Method M-073.1
(Reference 1).
Residues of avermectin B1a, avermectin B1b, and 8,9-Z avermectin B1a are extracted from
homogenized crop samples with acetonitrile:0.1% H3PO4 (25:75, v/v). The isolated residues
are then partitioned into hexane. A suitable aliquot of the hexane extract is purified using
aminopropyl solid phase extraction (SPE) cleanup. The purified extract is evaporated to
dryness, reconstituted in acetonitrile, then submitted to HPLC analysis. During routine
analysis, determination and quantitation of all targeted analytes are conducted using HPLC
employing mass spectrometric (MS/MS) detection (LC-MS/MS). The limit of quantitation
(LOQ) for all three analytes, in all matrices, is 0.002 ppm.
2 EQUIVALENCE STATEMENT
During the conduct of this analysis, comparable apparatus, solvents, glassware, and
techniques (such as sample extract evaporation) may be substituted for those described in
this method, except where specifically specified. In the event a substituted piece of
equipment or technique is used, its use will be documented in the study records.
Graduated mixing cylinders: Glass; 500, 250, 100, 50, and 25-mL
HPLC column: 50-mm × 2.0-mm i.d. Imtakt Cadenza CD-18, 3µ particle size
(Imtakt Corporation, Kyoto, Japan)
Pipets, electronic: EDP electronic pipets with 1000 µL (1.00 mL) to 10.0 mL
liquid ends and suitable pipet tips (Rainin Instrument Co.,
Inc., Ridgefield, NJ)
Platform shaker: Eberbach Model 6000 (Eberbach Corp., Ann Arbor, MI)
Solid Phase
Extraction Apparatus: Visiprep 12 or 24-port SPE vacuum manifold with disposable
flow control liners (Supelco, Bellefonte, PA)
Vac Elut SPS 24 (Varian Sample Preparation Products,
Harbor City, CA)
Solid phase
extraction cartridges: Bond Elut, Aminopropyl SPE cartridges, 500mg/3mL (Varian
Sample Preparation Products, Harbor City, CA)
4.1.1 0.1% phosphoric acid: To a 500-mL mixing cylinder, add approximately 400 mL deionized
water, then add 0.5 mL phosphoric acid (85%). Carefully swirl flask to mix contents. Bring
to a final volume of 500 mL with deionized water. Transfer to a properly labeled secondary
container. Mix well. Prepare as needed.
Morse Laboratories, Inc. Meth-192, Page 7
4.1.2 Acetonitrile:0.1% phosphoric acid (25:75, v/v): To a 500-mL mixing cylinder, add 125 mL
of acetonitrile and bring to a final volume of 500 mL with 0.1% phosphoric acid. Mix
thoroughly. Prepare as needed.
4.1.3 Ethyl acetate:methanol (75:25, v/v): To a 100-mL mixing cylinder, add 25 mL of methanol
and bring to a final volume of 100 mL with ethyl acetate. Mix thoroughly. Prepare as
needed.
5 REFERENCE STANDARDS
5.1 Abamectin
Structural Formula:
Avermectin B1a
Structural Formula:
Avermectin B1b
Structural Formula:
6 STANDARD PREPARATION
All standard solutions prepared in this section are to be stored in the freezer and in the dark
(typically at −8 to −22°C) when not in use. Avermectin B1a and avermectin B1b have been
shown to be stable for at least 111 days down to concentrations of 0.1 µg/mL when stored as
such in glass. HPLC calibration standards have been shown to be stable for at least 12 days
when stored under the same conditions.
Typically, 25.0 mg (corrected for purity), based on avermectin B1a, of analytical standard is
accurately weighed and quantitatively transferred to a 25-mL volumetric flask. The contents
are brought to a final volume of 25 mL with acetonitrile. The resulting concentration of the
solution is 1000 µg/mL with respect to avermectin B1a.
Morse Laboratories, Inc. Meth-192, Page 11
For example:
A Certificate of Analysis for a lot of abamectin primary standard states the abamectin
concentration is 90.7% (85.6% avermectin B1a and 5.1% is avermectin B1b)
Typically, 25.0 mg (corrected for purity) of analytical standard is accurately weighed and
quantitatively transferred to a 25-mL volumetric flask. The contents are brought to a final
volume of 25 mL with acetonitrile. The resulting concentration of the solution is 1000
µg/mL.
The stock standard solution concentration established for avermectin B1b as an example in
Section 6.1.1 above, is used for demonstration purposes for the following preparations.
10 µg/mL B1a/
0.596 µg/mL B1b: Transfer 250 µL of the "1000 µg/mL B1a/59.6 µg/mL B1b" stock
standard solution to a 25-mL volumetric flask. Bring to volume with
acetonitrile. Mix well.
Morse Laboratories, Inc. Meth-192, Page 12
0.1 µg/mL: Transfer 2.5 mL of the 1.0 µg/mL standard solution to a 25-mL
volumetric flask. Bring to volume with acetonitrile. Mix well.
25 µg/mL B1a/
1.49 µg/mL B1b/
25 µg/mL B1a Z-isomer: Transfer 625 µL of the "1000 µg/mL B1a/59.6 µg/mL B1b"
stock standard solution and 625 µL of the 1000 µg/mL
Z-isomer stock standard solution to a 25-mL volumetric flask.
Bring to volume with acetonitrile.
25 ng/mL B1a/
1.49 ng/mL B1b/
25 ng/mL B1a Z-isomer: Transfer 2.50 mL of the "250 ng/mL B1a/14.9 ng/mL B1b/
250 ng/mL B1a Z-isomer" standard solution to a 25-mL
volumetric flask. Bring to volume with acetonitrile.
Typically the following concentrations of mixed standard solutions containing all three
analytes (avermectin B1a, avermectin B1b, and 8,9-Z avermectin B1a) are prepared. Due to
the very low concentrations of avermectin B1b contained in the solutions, both avermectin
B1a and avermectin B1b residues are calculated using the calibration curve generated for
avermectin B1a. The highest concentration of standard solution analyzed does, however,
produce an avermectin B1b response that is sufficient for avermectin B1b peak identification.
7 SAMPLE FORTIFICATION
2. Fortify the sample with the appropriate amount of standard solution(s). Disperse
solution(s) over as much of the sample as possible. Use a volume of fortification
solution ≤0.5 mL.
8 SAMPLE EXTRACTION
2. Add 20 mL acetonitrile:0.1% phosphoric acid (25:75, v/v) solution to the sample in the
centrifuge tube.
3. Blend using a high-speed homogenizer at high speed for ~1 minute. Rinse the
blender probe by blending with 20 mL hexane contained in another 50 mL centrifuge
tube (see Note below). Add the hexane rinse solution to the original extract and
shake for ~5 minutes in a reciprocating (platform) shaker. Centrifuge the extract for
~10 minutes at about 2500 rpm.
Note: After each sample, rinse the blender probe with water followed by methanol.
4. Using a disposable polyethylene transfer pipet, transfer the hexane layer containing
the avermectins to a 100-mL polypropylene graduated cylinder.
Morse Laboratories, Inc. Meth-192, Page 15
5. Re-extract the aqueous remainder two additional times with 20 mL of hexane each
time. Combine the hexane extracts in the same 100-mL polypropylene graduated
cylinder. Bring to a final volume of 100 mL with hexane. Transfer to a 250-mL
HDPE centrifuge bottle and mix well (see Note 1 below). Add ~1 g of anhydrous
sodium sulfate. Briefly shake to remove traces of aqueous solution. Proceed to
Section 9 for aminopropyl SPE cleanup.
Note: Sample hexane extracts should not be stored overnight in glass containers
and processed the next day since avermectins tend to be adsorbed on to
glass surfaces when stored in hexane for extended periods of time.
Note: Check or calibrate the SPE cartridges prior to use in order to ensure optimum method
performance. In general, check one tube per lot number per box. This assessment
should be conducted well in advance of needing the tubes for sample analysis.
Recovery of >90% is desired to ensure that a box of tubes is suitable for use. The
analyses are conducted on a reagent spike basis. See Appendix III for detailed
instructions on assessment of the SPE tubes.
Procedure:
1. Set up SPE processing system and support apparatus and proceed with aminopropyl
SPE cleanup. In general, set vacuum to produce a flow rate of approximately 2-3
distinct drops/second (not continuous flow) for all elutions. Attach a 20-mL
reservoir with adaptor to the SPE cartridge.
3. Load the sample (10 mL aliquot of sample extract from Step 8.5, equivalent to 0.50 g
of sample) onto the cartridge. Stop elution when loading solvent reaches top of frit.
Discard the eluate to waste.
5. Place a silanized 13 × 100-mm test tube (calibrated at 2.5 ml) under the SPE
cartridge.
6. Using mild vacuum, elute the abamectin-related residues from the cartridge with 2.0
mL of ethyl acetate:methanol (75:25, v/v).
Note: Residual ethyl acetate:methanol (75:25, v/v) solution remaining in the SPE
cartridge should be drained and collected using moderate to high vacuum.
7. Evaporate the eluate to near dryness on an N-Evap evaporator @ ≤35 °C. Continue
evaporation to just-dry using manual nitrogen blowdown.
Note: Do not over-evaporate as abamectin residues have a tendency to irreversibly
adsorb onto glass surfaces, even when silanized. Handle manual evaporation
and redissolving of residue one sample at a time.
8. Immediately redissolve the residue in acetonitrile and bring to a final volume of 2.5
mL with acetonitrile. Cap, sonicate (mandatory) and mix well. Final sample
concentration: 1 mL = 0.2 g sample. Submit to LC/MS/MS analysis. Store sample
extracts in freezer (−8 to −22°C) if not analyzed immediately.
Note: The column and conditions stated in the method have been satisfactory for the
matrices being analyzed. The specific column packing, mobile phase, column
temperature and flow rate listed are typical conditions for this analysis. Alternate
columns may be used depending on the need to resolve analyte and/or interfering
responses. Specific conditions used will be noted on each chromatographic run and
will not otherwise be documented.
HPLC column: 50-mm × 2.0-mm i.d. Imtakt Cadenza CD-18, 3µ particle size
Mobile phase: Fisher water, Burdick and Jackson methanol, and Fisher
ammonium acetate
Gradient:
Percent of Percent of
Time (min) Mobile Phase A Mobile Phase B
0.00-0.50 35 65
10.0-10.4 5 95
10.5-13.0 35 65
Injection Volume: 5 µL
Column Temperature: 40 °C
Prepare a five-point standard curve by injecting constant volumes of standard solutions. Use
constant volume injections for sample extracts as well. Sample responses greater than those
produced by the highest concentration of standard curve require dilution and reinjection.
Inject a curve check standard every 3-4 sample injections.
11 CALCULATIONS
Calculations for instrumental analysis are conducted using a validated software application
to create a standard curve based on linear regression. The regression functions are used to
calculate a best fit line (from a set of standard concentrations in ng/mL versus peak response)
and to determine concentrations of the analyte found during sample analysis from the
calculated best fit line. Weighting (1/x) is used.
y = mx + b
where:
y = peak response
x = ng/mL found for peak of interest
m = slope
b = y-intercept
Morse Laboratories, Inc. Meth-192, Page 19
Note: The calibration curve generated for Avermectin B1a is also used to quantify residues
found for Avermectin B1b in field samples and fortified samples.
The calculations for ppm found and percent recovery (for fortified samples) are:
1. The amount of analyte (in ppm) found in the sample is calculated according to the
following equation:
where:
HPLC final vol. (mL) = volume of final extract submitted to HPLC (typically
2.5 mL)
12 REFERENCE
APPENDIX I
Analysis Flowchart
Morse Laboratories, Inc. Meth-192, Page 22
ANALYSIS FLOWCHART
(RAC Fruits and Vegetables)
Sample (5.00 g)
• weigh sample into 50-mL polypropylene centrifuge tube
• add 20 mL acetonitrile:0.1% phosphoric acid (25:75, v/v)
Blend
• blend using high speed homogenizer for ~1 minute
• rinse blender probe with 20 mL of hexane
• add rinse to extraction centrifuge tube
Shake
• shake on platform shaker for ~5 minutes
Centrifuge
• centrifuge mixture for ~10 min @ ~2500 rpm
Liquid/liquid partition
• draw off hexane layer and transfer to a 100-mL polypropylene
graduated cylinder
• extract aqueous remainder 2 more times with 20 mL hexane each
time.
• draw off hexane layers and transfer to the same 100-mL
polypropylene graduated cylinder, combining the hexane
extractions
• bring to a final volume of 100 mL with hexane, then transfer to a
250-mL HDPE centrifuge bottle and mix well. Add ~1 g of
anhydrous sodium sulfate and mix.
Aminopropyl SPE
• pass 10 mL of the diluted hexane extract thru a preconditioned
aminopropyl SPE cartridge
• wash sample-laden cartridge with 10 mL hexane (2 times), followed
by 3 mL ethyl acetate. Discard eluates.
• elute analytes with 2 mL ethyl acetate:methanol (75:25, v/v) into a
silanized 13×100-mm test tube
Evaporation
• evaporate to near dryness on a N-Evap evaporator @ ≤35°C, then
on to dryness with manual nitrogen blowdown
• redissolve residue in 2.5 mL acetonitrile
HPLC-MS/MS
Morse Laboratories, Inc. Meth-192, Page 23
APPENDIX II
Silylation of Glassware
Morse Laboratories, Inc. Meth-192, Page 24
All glassware to be silylated must be clean and free of organic (i.e., oils/gums) and/or inorganic (i.e.,
salts) residues and aged layers (>5 silylation treatments) of preexisting silylated coating residues.
Treatment with a cleaning agent such as Chem-Solv® will produce a properly clean/prepared surface
for silylation.
Glassware with unknown history or that requires the removal of aged layers of silylated coating
should be treated by exposing (maintaining reagent contact) the glass surfaces to 100% Chem-Solv®
a minimum of 10 minutes. For maintenance treatment, glassware previously properly prepared and
silylated should be similarly exposed to 50% Chem-Solv® (in water) a minimum of 5 minutes.
Insure that all surfaces which can come in contact with the analytes are properly treated. Rinse
thoroughly with DI water, followed by acetone. Allow to air dry.
Silylation of Glassware
Silylation is a process used to chemically treat glassware or other products in order to prevent or
minimize binding of analyte residues to the glass surface.
1. Pour a small amount of the 5% DMDCS solution (5 mL DMDCS + 95 mL hexane) into the
glassware to be treated. Stopper bulk container. Rotate the glassware to thoroughly coat the
inside surfaces. Pour excess solution into the next piece of glassware to be treated.
Note: Moisture in the air tends to inactivate this reagent. To insure maximum activity
of the silylating agent during the coating process, limit the exposure (to the
atmosphere) of the silylating agent to approximately 5 minutes.
2. Allow the treated glassware to dry (approximately 20 minutes). Rinse thoroughly with
hexane, then reagent acetone. Again allow to dry.
Notes: • Any glassware that is cleaned with a brush after it has been silylated, must be
resilylated.
• 5% solutions of DMDCS in hexane are stable for 5 days when stored well-
stoppered at room temperature. Choose a storage container with minimum
air space above the surface of the solution.
Morse Laboratories, Inc. Meth-192, Page 26
APPENDIX III
1. Transfer 10 µL of a "2.5 µg/mL B1a/0.149 µg/mL B1b/2.5 µg/mL B1a Z-isomer" mixed
standard solution (in acetonitrile) to a 16 × 100-mm silanized test tube containing 10.0 mL of
hexane. Mix well.
Transfer 100 µL of the solution from Step 3 to a silanized 13 × 100-mm test tube
containing 900 µL of acetonitrile. Mix well. Final concentration of the analytes are
0.149 ng/mL B1b and 2.5 ng/mL for both B1a and B1a Z-isomer (analytes of interest
in bold font).
APPENDIX IV
FIGURE 1. Full Scan MS Spectrum of ~1 µg/mL Avermectim B1a or 8,9-Z Avermectin B1a
Morse Laboratories, Inc. Meth-192, Page 30
FIGURE 2. MS/MS Full Scan (Q3 Scan) of an ~0.2 µg/mL Avermectim B1a or 8,9-Z
Avermectin B1a (Collision Energy Set to 60V)
Morse Laboratories, Inc. Meth-192, Page 31
895.4
Morse Laboratories, Inc. Meth-192, Page 32
FIGURE 4. MS/MS Full Scan (Q3 Scan) of an ~0.2 µg/mL Avermectin B1b Standard
(Collision Energy Set to 59V)